Molecular basis of resistance to azole antifungals

Trends in Molecular Medicine

Volumn 8, Issue 2, 2002, Pages 76-81

  Lupetti, Antonella ^a   Danesi, Romano ^a   Campa, Mario ^a   Tacca, Mario Del ^a   Kelly, Steven ^b  

^a UNIVERSITY OF PISA   (Italy)

^b ABERYSTWYTH UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CYTOCHROME P450; ERGOSTEROL; FLUCONAZOLE; FLUCYTOSINE; GENE PRODUCT; ITRACONAZOLE; KETOCONAZOLE; POLYENE ANTIBIOTIC AGENT; PYRROLE DERIVATIVE; TRIAZOLE DERIVATIVE;

ANTIBIOTIC RESISTANCE; BIOSYNTHESIS; CANDIDA ALBICANS; CELL MEMBRANE; DRUG MECHANISM; DRUG STRUCTURE; FUNGAL CELL; GENE CONTROL; HUMAN; MOLECULAR BIOLOGY; MYCOSIS; REVIEW;

CANDIDA; CANDIDA ALBICANS; FUNGI;

EID: 0036156041     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1471-4914(02)02280-3     Document Type: Review

References (58)

1. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance
2. Genetic and physiological analysis of azole sensitivity in Saccharomyces cerevisiae
3. 8-7 isomerase in a Cryptococcus neoformans strain from an AIDS patient
4. Amphotericin B-induced oxidative damage and killing of Candida albicans
5. 19F nuclear magnetic resonance study of fluoropyrimidine metabolism in strains of Candida glabrata with specific defects in pyrimidine metabolism
6. Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: Experience with twenty-one patients
7. Molecular aspects of azole antifungal action and resistance
8. Resistance to fluconazole and cross-resistance to amphotericin B in Candida albicans from AIDS patients caused by defective sterol δdesaturation
9. Phospholipid and sterol analysis of plasma membranes of azole-resistant Candida albicans strains
10. Transcriptional analyses of antifungal drug resistance in Candida albicans
11. Distinct patterns of gene expression associated with development of fluconazole resistance in serial Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis
12. Rapid, transient fluconazole resistance in Candida albicans is associated with increased mRNA levels of CDR
13. Specific chromosome alterations in fluconazole resistant mutants of Candida albicans
14. Inducible azole resistance associated with a heterogeneous phenotype in Candida albicans
15. High-frequency, in vitro reversible switching of Candida lusitaniae clinical isolates from amphotericin B susceptibility to resistance
16. AntifungaI drug resistance in pathogenic fungi
17. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: Characterization of CDR2, a new multidrug ABC transporter gene
18. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases in azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus
19. In vitro antifungal activity of BMS-207147 and itraconazole against yeast strains that are non-susceptible to fluconazole
20. In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents
21. Non-albicans oral candidosis in HIV-positive patients
22. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents
23. Origin of differences in susceptibility of Candida krusei to azole antifungal agents
24. Identification and expression of multidrug resistance-related ABC transporter genes in Candida krusei
25. Resistance of Candida species to fluconazole
26. National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans - Frequency of occurrence and antifungal susceptibility in the SCOPE program
27. Candida glabrata: Review of epidemiology, pathogenesis, and clinical disease with comparison to Candida albicans
28. Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata
29. In-vitro resistance to azoles associated with mitochondrial DNA deficiency in Candida glabrata
30. In-vivo selection of an azole-resistant petite mutant of Candida glabrata
31. Multiple signals from dysfunctional mitochondria activate the pleiotropic drug resistance pathway in Saccharomyces cereviasiae
32. Interorganellar communication. Altered nuclear gene expression profiles in a yeast mitochondrial DNA mutant
33. Mitochondrial fusion in yeast requires the transmembrane GTPase Fzolp
34. OXA1, a Saccharomyces cerevisiae nuclear gene whose sequence is conserved from prokaryotes to eukaryotes controls cytochrome oxidase biogenesis
35. Identification of the essential yeast protein MIM17, an integral mitochondrial inner membrane protein involved in protein import
36. Experimental induction of fluconazole resistance in Candida tropicalis ATCC 750
37. Molecular biological characterization of an azole-resistant Candida glabrata isolate
38. Upregulation of ERG genes in Candida species by azoles and other sterol biosynthesis inhibitors
39. Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray
40. Genome-wide expression patterns in Saccharomyces cerevisiae: Comparison of drug treatments and genetic alterations affecting biosynthesis of ergosterol
41. Resistance to fluconazole in Candida albicans from AIDS patients involving cross-resistance to amphotericin
42. Modulation of fluconazole sensitivity by the interaction of mitochondria and Erg3p in Saccharomyces cerevisiae
43. Accumulation of 3-ketosteroids induced by itraconazole in azole-resistant clinical Candida albicans isolates
44. Biochemical characterization and subcellular localization of the sterol C-24(28) reductase, erg4p, from the yeast Saccharomyces cerevisiae
45. Mechanism of fluconazole resistance in Candida krusei
46. Molecular analysis of CYP51 from fluconazole resistant Candida albicans
47. CAM
48. The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14α-demethylase in Candida albicans
49. The mutation T315A in Candida albicans sterol 14α-demethylase causes reduced enzyme activity and fluconazole resistance through reduced affinity
50. Amino acid substitutions in the cytochrome p-450 lanosterol 14α-demethylase (CYP51A1) from azole-resistant Candida albicans clinical isolates contribute to resistance to azole antifungal agents
51. The G464S amino acid substitution in Candida albicans sterol 14α-demethylase causes fluconazole resistance in the clinic through reduced affinity
52. Y132H substitution in Candida albicans sterol 14α-demethylase confers fluconazole resistance by preventing binding to haem
53. The R467K amino acid substitution in Candida albicans sterol 14α-demethylase causes drug resistance through reduced affinity
54. Multiple amino acid substitutions in lanosterol 14α-demethylase contribute to azole resistance in Candida albicans
55. Contribution of mutations in the cytochrome P450 14α-demethylase (Erg11p, CYP51) to azole resistance in Candida albicans
56. Genetic analysis of azole resistance in the Darlington strain of Candida albicans
57. Reverse cross blot hybridization assay for rapid detection of PCR-amplified DNA from Candida species, Cryptococcus neoformans, and Saccharomyces cerevisiae in clinical samples
58. Genomic profiling of drug sensitivities via induced haploinsufficiency